BioStock: Cyxone is looking forward to an eventful autumn

When Tara Heitner came in as new CEO for the Malmö-based biotech company Cyxone, it marked the start of an increase in activity within the company. Shortly after she took office in June, they announced filing of new patents, recruited new scientific advisors, a head of development and established a new collaboration within a new therapeutic area. The news got the share price increasing by more than 40 per cent during summer and has ignited expectations on further value enhancing events to come.

Read the full article about Cyxone at biostock.se:

https://www.biostock.se/2020/09/cyxone-ser-fram-emot-en-handelserik-host/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/